Executive Director, Global Value and Access

Location: San Rafael
Posted on: June 23, 2025

Job Description:

Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health. Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities. Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options. About Commercial Our Commercial organization leads our global sales and marketing strategies around the world. Our integrated team continues to solidify BioMarin’s commercial presence in the United States and Europe, Latin America, the Middle East and Asia-Pacific. Position Overview: The Executive Director, Global Value and Access will report to the SVP Global Value Access and Strategic Pricing (GVASP) and will be part of the GVASP Leadership Team. This role will lead a team of V&A experts responsible for developing and executing differentiated global market access and pricing strategies that demonstrate the value of our innovative therapies and support optimal patient access while also directly shaping those strategies. The ideal candidate will have a demonstrable track record of developing and/or overseeing the development of innovative access and pricing strategies, key value materials and tools in multiple markets. A solid analytical background, strategic thinking, a deep understanding of U.S. and international healthcare systems (including but not limited to Brazil, Germany, Italy and Japan), payer requirements, preferences, and market dynamics is required. Rare diseases experience is preferred. Responsibilities: Accountability for the development of Global Integrated Access and Pricing strategies to maximize the value of our current and future assets by a team of direct reports (Global and Local) V&A Leads and other Global, Regional and Local partners. Accountability for the creation and governance of V&A key deliverables for the portfolio of products and pipeline assets in alignment with Business Units and International partners. Leading a high-performing direct (Global and Local) and matrixed team of Value, Access and Pricing experts. Ensuring strategic market access input is provided to guide global clinical development programs, so these are optimized to meet the needs of global payers. Experience collecting and incorporating payers’ and other stakeholder’ perspectives through early engagement with ad boards, primary research, and analysis of select secondary research is required. Overseeing and actively participating in the generation of the global V&A strategy, integrated evidence plans input, value propositions, and stakeholder engagement planning. Developing and maintaining strong business relationships with key functions responsible for value proposition enablement, focusing on Clinical, Commercial, Regulatory, Medical Affairs and Government Affairs and HEOR. Overseeing the identification and communication of evidence requirements for successful access of our products and supporting the development of evidence generation plans in collaboration with HEOR and Medical Affairs. Ability to communicate and influence effectively is a must. Driving the design of V&A services and key deliverables for optimal alignment, support, and efficiency. And co-leading international best practice sharing with the V&A Head of International markets and Head of U.S V&A. Monitoring, analyzing, and communicating global market access and pricing trends, competitor activities, and policy changes to anticipate future market dynamics to build new capabilities and adjust strategies accordingly. Supporting the execution of broader market access goals, including pricing targets, access timelines, and overall launch success. Leading the development of pricing estimates, value propositions and access plans for pipeline and potential assets acquisitions. Providing strategic leadership as an active member of GV&A's leadership team (LT) and shaping the team's strategy, priorities, and activities in partnership with other leaders and the Head of GVASP. Requirements: Ph. D, Pham D, M.D., M. Sc. in an appropriate field (Life Sciences, Health Economics, Public Health, Health Policy or Medicine) preferred. 15 years of relevant experience working within a similar organization, including international exposure within a leadership position. Strong experience in pricing and reimbursement with specific knowledge of and demonstrated experience in one of the key HTA markets (i.e., UK, Germany, France, Canada). Rare diseases experience preferred. Strong experience with pricing regulations and a hands-on role in early and launch pricing analysis. Demonstrable experience supporting early global development plans to meet the evidence requirements for various downstream market access stakeholders. Proven track record of success within developing desirable value propositions and access strategies. Demonstrated knowledge of global policy trends, tactics, and HTA/payer dynamics. Experience in making market access recommendations on products in development and suggesting changes for optimization of market access. Demonstrated success in managing multiple activities and working in a fast-paced environment. Proven track record of providing thought leadership, influencing decisions across all levels of the organization, and driving results through teams. Demonstrated ability to shape the policy environment to support the development of new funding streams. Expertise in strategic pricing, contracting, and negotiation, including innovative approaches and experience developing pricing strategies and business cases. Advanced understanding of the pharmaceutical product lifecycle, including experience with market access launch planning, execution, and drivers of value. Significant experience developing global V&A strategies, including developing global value messages, integrated evidence planning, and creating tools to support implementation in key markets. Experience with early-stage assets, including conducting commercialization assessments and providing V&A guidance into target product profiles and development plans. Proven track record managing a high-performing team, building a distinctive team culture in a globally dispersed team, and developing people through coaching and mentoring. Demonstrated ability to lead and influence cross-functionally while serving as a highly skilled facilitator, negotiator, and counselor. Broader commercial experience beyond value and access is a plus. Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned. Equal Opportunity Employer/Veterans/Disabled An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.

Keywords: , Woodland , Executive Director, Global Value and Access, Science, Research & Development , San Rafael, California